Skip to content

Impact analysis of the Fractional exhaled Nitric Oxide (FeNO) test as add-on test in the diagnostic work-up of asthma

Impact analysis of the Fractional exhaled Nitric Oxide (FeNO) test as add-on test in the diagnostic work-up of asthma - INFERNO

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON53629
Enrollment
171
Registered
2023-03-28
Start date
2023-07-01
Completion date
Unknown
Last updated
2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma

Interventions

Standard care • Consult pulmonary physician • Blood sampling • Spirometry • Visual Analogue Scale (VAS) and Asthma Quality of Life Questionnaire (AQLQ) • Asthma Control Questionnaire (ACQ) Visit 1

Sponsors

Franciscus Gasthuis & Vlietland
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: • Patients >= 18 years, referred by the general practitioner to the outpatient clinic pulmonology with the suspicion of asthma • Patients without reversibility at the spirometry (delta FEV1 >= 200 ml and >=12% improvement) • Patients understand the Dutch or English language for giving informed consent and to complete the questionnaires • They can discontinue their medication (discontinuation time depends on the kind of medication, paragraph 3.2)

Exclusion criteria

Exclusion criteria: Patients will be excluded if: • They have a fixed obstruction or with already the diagnose with asthma based on prior tests • They are pregnant

Design outcomes

Primary

MeasureTime frame
Main study endpoint: • (Theoretical) reduction of BPTs

Secondary

MeasureTime frame
Secondary endpoints: • Direct healthcare costs of diagnosis (avoidable BPTs, extra costs of FeNOs, extra diagnose costs in FeNO >= 50 ppb and negative BPT) • The diagnostic burden of FeNO testing and BPT testing (VAS -score and AQLQ) • Asthma control (ACQ) Secondary parameters: - Patient characteristics - Asthma profile (eosinophils, sIgE to inhalation allergens) - Lung function (FEV1 and Forced Vital Capacity (FVC) and FVC/ FEV1) - Outcome BPT (positive/negative) - FeNO test outcome (ppb)

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: Feb 3, 2026